A carregar...
IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection
IL15 is a key cytokine for the activation and survival of anti-tumor effectors CD8(+) T and NK cells. Recently published preclinical studies demonstrate that the therapeutic activity of IL15 requires conventional dendritic cells type 1 (cDC1). Radiotherapy cooperates with IL15 by enhancing cDC1 tumo...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466855/ https://ncbi.nlm.nih.gov/pubmed/32934886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1790716 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|